Suraksha Diagnostic Ltd

Suraksha Diagno. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Suraksha Diagnostic Ltd

₹ 301 0.23%
14 Aug 1:16 p.m.
surakshanet.com BSE: 544293 NSE: SURAKSHA
About

Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution.[1]

Key Points

Business Model[1][2]
a) Integrated Services: Offers a one-stop solution for pathology, radiology, and medical consultancy services.
b) Comprehensive Testing: Provides 2,300+ diagnostic tests, ranging from routine pathology to advanced radiology.
c) Hub and Spoke Model: Operates through a central reference lab, 8 satellite labs, and a network of diagnostic and collection centers for efficient sample processing and service delivery.
d) Omni-channel Consultation: Combines online and offline medical consultation services, leveraging its polyclinics with 1,000+ doctors.
e) B2C-Focused Revenue Model: Primarily serves individual patients, with some revenue from B2B contracts.

Website BSE NSE
  • Market Cap ₹ 1,570 Cr.
  • Current Price ₹ 301
  • High / Low ₹ 449 / 231
  • Stock P/E 48.4
  • Book Value ₹ 40.6
  • Dividend Yield 0.00 %
  • ROCE 17.8 %
  • ROE 16.0 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 7.41 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 9.86% over past five years.
  • Company has a low return on equity of 12.4% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of BSE Healthcare BSE SmallCap BSE IPO BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
60.05 51.82 55.19 60.73 66.75 59.51 65.09 72.59
39.22 36.50 35.72 40.12 43.55 41.26 45.91 48.85
Operating Profit 20.83 15.32 19.47 20.61 23.20 18.25 19.18 23.74
OPM % 34.69% 29.56% 35.28% 33.94% 34.76% 30.67% 29.47% 32.70%
0.56 0.85 0.20 1.12 1.31 0.60 0.82 0.91
Interest 2.48 2.03 2.08 2.22 2.13 1.98 2.06 2.70
Depreciation 7.95 7.92 8.36 8.99 8.75 8.83 8.73 9.48
Profit before tax 10.96 6.22 9.23 10.52 13.63 8.04 9.21 12.47
Tax % 24.00% 27.01% 31.53% 27.00% 25.53% 25.62% 22.15% 26.46%
8.34 4.53 6.32 7.67 10.15 5.98 7.17 9.18
EPS in Rs 121.88 67.39 94.49 1.84 2.40 1.18 1.42 1.80
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
158 140 223 190 219 252 264
123 115 175 143 146 170 180
Operating Profit 34 25 48 47 73 82 84
OPM % 22% 18% 22% 25% 33% 33% 32%
2 -1 2 1 1 4 4
Interest 2 2 2 10 10 9 9
Depreciation 13 16 15 32 33 35 36
Profit before tax 21 6 33 7 31 41 43
Tax % 28% -1% 28% 10% 26% 25%
15 6 24 6 23 31 32
EPS in Rs 220.43 93.33 344.20 94.49 342.46 6.11 6.80
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 10%
3 Years: 4%
TTM: 16%
Compounded Profit Growth
10 Years: %
5 Years: 16%
3 Years: 9%
TTM: 19%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 12%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 7 7 7 7 7 10
Reserves 111 118 141 147 171 201
13 18 21 99 92 89
42 28 32 28 30 33
Total Liabilities 173 171 201 281 300 334
128 119 119 195 212 223
CWIP 0 0 1 2 1 11
Investments 5 5 0 0 0 1
39 46 80 84 87 99
Total Assets 173 171 201 281 300 334

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
31 24 42 44 60 63
-20 -28 -44 -21 -35 -40
-10 3 1 -24 -25 -24
Net Cash Flow 1 -1 -0 -1 0 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 14 16 12 9 15 20
Inventory Days 93 62 38 82 89 100
Days Payable 227 177 84 187 193 169
Cash Conversion Cycle -120 -99 -34 -96 -89 -49
Working Capital Days -35 -19 -15 -49 -37 -23
ROCE % 8% 23% 9% 17% 18%

Shareholding Pattern

Numbers in percentages

14 Recently
Dec 2024Mar 2025Jun 2025
48.78% 48.78% 48.89%
15.39% 14.46% 13.95%
20.43% 22.05% 22.37%
15.39% 14.71% 14.79%
No. of Shareholders 98,66287,27579,670

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls